- Home
- »
- Medical Devices
- »
-
Biosensors Market Size, Share And Trends Report, 2030GVR Report cover
![Biosensors Market Size, Share & Trends Report]()
Biosensors Market Size, Share & Trends Analysis Report By Technology (Electrochemical, Thermal, Piezoelectric), By Application By End-user, And Segment Forecasts, 2024 - 2030
- Report ID: 978-1-68038-321-8
- Number of Report Pages: 110
- Format: PDF, Horizon Databook
- Historical Range: 2018 - 2022
- Forecast Period: 2024 - 2030
- Industry: Healthcare
Biosensors Market Size & Trends
The global biosensors market size was estimated at USD 28.9 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2030. The demand for biosensors is increasing due to the diversity of medical applications, increasing number of diabetic patients, high demand for compact diagnostic devices, and rapid technological improvement.Accurate early diagnosis of the disease is critical to a positive disease prognosis and patient survival. Demand for disposable, convenient, and economical devices with fast response times has increased dramatically in recent years. The emergence of COVID-19 had a positive impact on the medical device industry. Early symptoms of COVID-19 were scanned using a variety of methods.
The biosensors market is on the verge of substantial expansion, driven by noteworthy technological advancements and strategic endeavors by key market players. For instance, in January 2023, Intricon, a developer and manufacturer of medical devices leveraging smart miniaturized electronics, made a significant stride by inaugurating a Biosensors Center of Excellence (CoE). This strategic move highlights Intricon's commitment to integrating its expertise and capabilities in a vertically integrated business unit devoted to introducing biosensor devices to the medical market. Combining technological innovation with a specific focus drives positive growth in the biosensors market.
Nanotechnology-based biosensors are expected to have wide application scope in various industries, such as food analysis, imaging, and microbial activity monitoring. The global market is consolidating due to the growing preference for non-invasive biosensors, rising popularity of medical devices & specialty drugs, and increasing research collaborations & contracts between various manufacturers. For example, Ethicon Endo-Surgery Inc.under contracts administered by Johnson & Johnson Innovation. Another important factor boostingindustry growth is the rising awareness about continuous health monitoring. As a result, the interest of athletes is increasing. Many athletes use Electromyography (EMG) biosensors to keep a close eye on their health and get alerts if something goes wrong.
This early detection can help athletes perform better and stay ahead of their competition. For example, in December 2022, biosensor company Nix launched its first consumer product, Nix Hydration Biosensor. The Hydration Nix Biosensor consists of a Bluetooth-enabled reusable module, a mobile app, and a single-use patch.Despite these considerations, the global market is expected to be constrained by strict regulations and complex cost recovery policies in the global healthcare sector. In addition, existing regulations are slow to adapt to new technologies, hindering product adoption and limiting industry development. The global biosensors market growth is projected to be driven by government programmes focused on the development of proteomics and genomics.
National Information and Communication Technology Australia (NICTA), for example, is projected to expand its data mining, networks, and embedded systems research in this subject. The majority of IT firms are also heavily investing in this sector. Market growth is also driven by investments from major IT companies, such as IBM, Infosys, and TCS. Furthermore, the Chinese government is heavily investing in its computing infrastructure, primarily through the China Grid, which was launched by the Chinese Academy of Sciences, the Ministry of Education, and the China National Grid (CNGrid), supported by the Ministry of Science & Technology. The presence of such beneficial initiatives is projected to boost the market growth.
However, the biosensors market encounters significant challenges, including the necessity for developing compatible single-task tools alongside existing software. The market growth is hindered by a substantial volume of data lacking standardization, impeding seamless integration. There is a crucial demand for user-friendly databases to streamline the analysis of extensive data held by institutions and governments globally, reducing both effort and time.
Market Concentration & Characteristics
Biosensors have made rapid advances in the medical field due to their ability to meet various criteria through a combination of interdisciplinary approaches in chemistry, nanotechnology, and medicine. The market growth is influenced by a number of factors that affect industry dynamics in both positive and negative ways. Furthermore, consumers are being urged to use biosensors for regular detection of pathogenic activities in the body due to the prevalence of chronic and lifestyle-related ailments, which is projected to drive product demand.
The application of biosensors is increasing due to growing elderly population worldwide and availability & affordability in conducting diagnostic tests. Diagnostic laboratories require various skills to test hundreds of samples per day; thus, the introduction of new-age biosensors will drive segment growth. For instance, in January 2023, researchers from the National Institute of Standards and Technology (NIST), Brown University, and CEA-Leti developed a diagnostic biosensor chip to offer accurate and inexpensive DNA biomarker identification. The key differential in the biomarker chip is its modular design, which allows manufacturers to lower the manufacturing cost.
Technology Insights
Based on technology, the industry is categorized into piezoelectric, electrochemical, thermal, and optical. The electrochemical segment captured the largest market share of around 71.5% in 2023 and is expected to grow at the fastest CAGR of 8.2% from 2024 to 2030. This is due to its ubiquitous use in biochemical and biological processes for measurement and analysis. Low detection limits, wide linear response range, excellent stability, and repeatability are all advantages of electrochemical biosensors. Electrochemical detection has a number of advantages over piezoelectric, thermal, and optical detection, resulting in higher market penetration and consumption.
Robustness, compatibility with new microfabrication technologies, ease of operation, low cost, disposability, independence from sample turbidity, and low power needs are among a few benefits. The optical segment is expected to witness the fastest CAGR from 2024 to 2030. The need for optical biosensors in the analysis is predicted to increase throughout the forecast period owing to their broad analytical coverage. Receptor-cell interactions, fermentation monitoring, structural research, concentration, kinetic, and equilibrium analyses are all possible with optical biosensors. The market for optical biosensors is expected to grow as a result of these factors.
Application Insights
Based on applications, the industry is segmented into bioreactor, medical, agriculture, environment, food toxicity, and others. In 2023, the medical segment dominated the industry and accounted for around 66.8% of the total revenue share. Biosensors are used in the fields of cholesterol testing, blood glucose monitoring, drug discovery, pregnancy testing, blood gas analyzer, and infectious disorders in the medical segment. It is regarded as a vital instrument in the identification and monitoring of a wide range of medical diseases, including diabetes and cancer.The agriculture segment will register the fastest CAGR of 9.1% from 2024 to 2030.
In comparison to traditional techniques used to prevent the loss of livestock and crops due to natural threats and bioterrorism, biosensors allow rapid and specific identification of numerous funguses. Pesticides, heavy metals, and herbicides, as well as pesticides in the ground and soil water, are measured with this instrument. These are also utilized to predict the emergence of soil disease, which was previously impossible with conventional technology, and thus, provide dependable, improved methods for soil disease cleanup and prevention at an early stage. These factors boost the market’s expansion.
End-user Insights
The end-user segment includes research laboratories, the food industry, home healthcare diagnostics and security POC testing, and bio-defense. Biosensors in point-of-care testing led the market in 2023 accounting for a revenue share of 47.3%. Key factors driving the segment growth include technological advancements that create innovative products, such as ultra-sensitive printable biosensors for PoC applications that help detect or monitor organic fluids like urine, saliva, blood, and sweat.
For instance, in August 2022, NanoDx, Inc., a developer of innovative medical diagnostic solutions, and SkyWater Technology announced the first commercially available protein-responsive nano biosensor. The food industry segment is anticipated to witness the fastest CAGR of 9.1% from 2024 to 2030. Its capacity to tackle many issues in the food processing sector, such as minimizing expenses incurred during hygiene analysis by precise tests and offering speedy findings, are key elements contributing to its rapid growth. There are some potential application areas of biosensors in the food industry including fast analysis of food to keep the product freshness and raw material inspections on a regular basis.
Regional Insights
North America held the largest share of more than 39.60% of the revenue in 2023 owing to the presence of key players and high incidence of targeted diseases in the region. Over the projected period, technological improvements, such as the introduction of miniaturized diagnostic equipment that provides increased market penetration of Electronic Medical Records (EMR), as well as precise & quick findings, are expected to fuel market expansion. Furthermore, the Clean Air Act, Clean Water Act, and National Environmental Policy Act all exist in the U.S. and are projected to create growth possibilities for the regional market.
Middle East and & Africa is expected to witness the fastest CAGR of 12.1% from 2024 to 2030. The presence of significant unmet medical requirements for target diseases, such as cancer, diabetes, and other infectious diseases, as well as continuously improving healthcare expenditure in the region and increasing patient awareness, drive the regional market growth. Increasing demand for home healthcare, PoC, and other healthcare businesses serving the adult population and government efforts to reduce hospital stays through the creation of outpatient care models are likely to drive market growth.
Key Biosensors Company Insights
The market is highly competitive. Key players focus on various strategic initiatives, such as new product launches, geographical expansions, mergers & acquisitions, collaborations, product upgradations, and partnerships, to gain higher industry share.
Some of the key players operating in the market include Bio-Rad Laboratories Inc.; Medtronic; Abbott Laboratories; Biosensors International Group, Ltd.; Johnson & Johnson; Koninklijke Philips N.V.; Nova Biomedical; and Siemens Healthcare.
-
Medtronic is a global health solutions company engaged in the development, manufacturing, distribution, and commercialization of device-based medical therapies and services. Organized into four segments—minimally invasive therapies, cardiac & vascular group, restorative therapies, and diabetes group—Medtronic operates globally with a presence in over 370 locations across approximately 160 countries. The company's products find applications in surgical centers, hospitals, home care, and long-term care facilities. Medtronic utilizes direct representatives in the U.S. and employs independent distributors and direct marketing methods in international markets to market its diverse range of medical solutions.
-
Abbott is a prominent global healthcare company dedicated to the development, manufacturing, and commercialization of healthcare products worldwide. The company operates through four key segments: pharmaceutical products, diagnostic products, nutritional products, and medical devices. Additionally, Abbott is a leading provider of blood glucose monitoring systems. With a widespread global presence, Abbott conducts operations in over 160 countries, emphasizing its commitment to addressing healthcare needs on a global scale. Notably, Abbott's subsidiary, St. Jude Medical, contributes to the company's diverse portfolio and overall impact in the healthcare industry.
Key Biosensors Companies:
The following are the leading companies in the biosensors market. These companies collectively hold the largest market share and dictate industry trends. Financials, strategy maps & products of these biosensors companies are analyzed to map the supply network.
- Bio-Rad Laboratories Inc.
- Medtronic
- Abbott Laboratories
- Biosensors International Group, Ltd.
- Pinnacle Technologies Inc.
- Ercon, Inc.
- DuPont Biosensor Materials
- Johnson & Johnson
- Koninklijke Philips N.V.
- LifeScan, Inc.
- QTL Biodetection LLC
- Molecular Devices Corp.
- Nova Biomedical
- Molex LLC
- TDK Corp.
- Zimmer & Peacock AS
- Siemens Healthcare
Recent Developments
- In January 2023, Intricon Corporation announced the opening of a Bionsensor Center of Excellence (CoE). The center aims to vertically integrate the company’s business to provide biosensors in medical devices.
Biosensors Market Report Scope
Report Attribute
Details
Market size value in 2024
USD 31.29 Billion
Revenue forecast in 2030
USD 49.78 Billion
Growth rate
CAGR of 8.04% from 2024 to 2030
Actual data
2018 - 2022
Forecast period
2024 - 2030
Quantitative units
Revenue in USD million/billion, volume in unit, and CAGR from 2024 to 2030
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Technology, application, end-user, region
Regional scope
North America; Europe; Asia Pacific; Latin America; MEA
Country scope
U.S.; Canada; UK; Germany; France; Italy; Spain; Belgium; Switzerland; The Netherlands; Sweden; Norway; Denmark; Japan; China; India; Australia; South Korea; Thailand; Indonesia; Brazil; Mexico; Colombia; Argentina; South Africa; Saudi Arabia; UAE; Turkey; Kuwait
Key companies profiled
Bio-Rad Laboratories Inc.; Medtronic; Abbott Laboratories; Biosensors International Group, Ltd.; Pinnacle Technologies Inc.; Ercon, Inc.; DuPont Biosensor Materials; Johnson & Johnson; Koninklijke Philips N.V.; LifeScan, Inc.; QTL Biodetection LLC; Molecular Devices Corp.; Nova Biomedical; Molex LLC; TDK Corp.; Zimmer & Peacock AS; Siemens Healthcare
Customization scope
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Biosensors Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the biosensors market report on the basis of technology, application, end-user, and region:
-
Technology Outlook (Volume, Unit; Revenue, USD Million, 2018 - 2030)
-
Thermal
-
Electrochemical
-
Piezoelectric
-
Optical
-
-
Application Outlook (Volume, Unit; Revenue, USD Million, 2018 - 2030)
-
Medical
-
Cholesterol
-
Blood Glucose
-
Blood Gas Analyzer
-
Pregnancy Testing
-
Drug Discovery
-
Infectious Disease
-
-
Food Toxicity
-
Bioreactor
-
Agriculture
-
Environment
-
Others
-
-
End-user Outlook (Volume, Unit; Revenue, USD Million, 2018 - 2030)
-
Home Healthcare Diagnostics
-
POC Testing
-
Food Industry
-
Research Laboratories
-
Security and Bio-Defense
-
-
Regional Outlook (Volume, Unit; Revenue, USD Million, 2018 - 2030)
-
North America
-
U.S.
-
Canada
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Belgium
-
Switzerland
-
The Netherlands
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
Japan
-
China
-
India
-
Australia
-
South Korea
-
Indonesia
-
Thailand
-
-
Latin America
-
Brazil
-
Mexico
-
Argentina
-
Colombia
-
-
Middle East and Africa (MEA)
-
South Africa
-
Saudi Arabia
-
UAE
-
Turkey
-
Kuwait
-
-
Frequently Asked Questions About This Report
b. The global biosensors market size was estimated at USD 28.9 billion in 2023 and is expected to reach USD 31.29 billion in 2024.
b. The global biosensors market is expected to grow at a compound annual growth rate of 8.04% from 2024 to 2030 to reach USD 49.78 billion by 2030.
b. The electrochemical segment dominated the global biosensors market and accounted for the largest revenue share of 71.5% in 2023.
b. The POC testing segment dominated the global biosensors market and accounted for the largest revenue share of around 47.3% in 2023.
b. The medical segment dominated the global biosensors market and accounted for the largest revenue share of 66.8%.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Biosensors Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Biosensors Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Biosensors Market: Technology Estimates & Trend Analysis
4.1. Technology Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Biosensors Market by Technology Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Thermal
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Electrochemical
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Piezoelectric
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Optical
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Biosensors Market: Application Estimates & Trend Analysis
5.1. Application Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Biosensors Market by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Medical
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Cholesterol
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Blood Glucose
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Blood Gas Analyzer
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Pregnancy Testing
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.6. Drug Discovery
5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.7. Infectious Disease
5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.8. Food Toxicity
5.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.9. Bioreactor
5.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.10. Agriculture
5.4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.11. Environment
5.4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.12. Others
5.4.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Biosensors Market: End-use Estimates & Trend Analysis
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Biosensors Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Home Healthcare Diagnostics
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.2. POC Testing
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.3. Food Industry
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.4. Research Laboratories
6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.5. Security and Bio-Defense
6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD million)
Chapter 7. Biosensors Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/ reimbursement structure
7.6.4.3. Competitive scenario
7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework/ reimbursement structure
7.6.5.3. Competitive scenario
7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework/ reimbursement structure
7.6.6.3. Competitive scenario
7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework/ reimbursement structure
7.6.7.3. Competitive scenario
7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework/ reimbursement structure
7.6.8.3. Competitive scenario
7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.6.9. Netherlands
7.6.9.1. Key country dynamics
7.6.9.2. Regulatory framework/ reimbursement structure
7.6.9.3. Competitive scenario
7.6.9.4. Netherlands market estimates and forecasts 2018 to 2030 (USD Million)
7.6.10. Belgium
7.6.10.1. Key country dynamics
7.6.10.2. Regulatory framework/ reimbursement structure
7.6.10.3. Competitive scenario
7.6.10.4. Belgium market estimates and forecasts 2018 to 2030 (USD Million)
7.6.11. Switzerland
7.6.11.1. Key country dynamics
7.6.11.2. Regulatory framework/ reimbursement structure
7.6.11.3. Competitive scenario
7.6.11.4. Switzerland market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/ reimbursement structure
7.7.5.3. Competitive scenario
7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework/ reimbursement structure
7.7.6.3. Competitive scenario
7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.7.7. Indonesia
7.7.7.1. Key country dynamics
7.7.7.2. Regulatory framework/ reimbursement structure
7.7.7.3. Competitive scenario
7.7.7.4. Indonesia market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework/ reimbursement structure
7.8.1.3. Competitive scenario
7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework/ reimbursement structure
7.8.2.3. Competitive scenario
7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework/ reimbursement structure
7.8.3.3. Competitive scenario
7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.8.4. Colombia
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework/ reimbursement structure
7.8.4.3. Competitive scenario
7.8.4.4. Colombia market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework/ reimbursement structure
7.9.1.3. Competitive scenario
7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework/ reimbursement structure
7.9.2.3. Competitive scenario
7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory framework/ reimbursement structure
7.9.3.3. Competitive scenario
7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory framework/ reimbursement structure
7.9.4.3. Competitive scenario
7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
7.9.5. Turkey
7.9.5.1. Key country dynamics
7.9.5.2. Regulatory framework/ reimbursement structure
7.9.5.3. Competitive scenario
7.9.5.4. Turkey market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.4. Company Profiles
8.4.1. BIO-RAD LABORATORIES INC.
8.4.1.1. Company overview
8.4.1.2. Financial Performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. MEDTRONIC
8.4.2.1. Company overview
8.4.2.2. Financial Performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. ABBOTT LABORATORIES
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Product benchmarking
8.4.4. BIOSENSORS INTERNATIONAL GROUP, LTD.
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. PINNACLE TECHNOLOGIES INC.
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. ERCON, INC.
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. DUPONT BIOSENSOR MATERIALS
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. JOHNSON & JOHNSON
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. KONINKLIJKE PHILIPS N.V.
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. LIFESCAN, INC.
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
8.4.11. QTL BIODETECTION LLC.
8.4.11.1. Company overview
8.4.11.2. Financial performance
8.4.11.3. Product benchmarking
8.4.11.4. Strategic initiatives
8.4.12. MOLECULAR DEVICES CORPORATION
8.4.12.1. Company overview
8.4.12.2. Financial performance
8.4.12.3. Product benchmarking
8.4.12.4. Strategic initiatives
8.4.13. NOVA BIOMEDICAL
8.4.13.1. Company overview
8.4.13.2. Financial performance
8.4.13.3. Product benchmarking
8.4.13.4. Strategic initiatives
8.4.14. MOLEX LLC
8.4.14.1. Company overview
8.4.14.2. Financial performance
8.4.14.3. Product benchmarking
8.4.14.4. Strategic initiatives
8.4.15. TDK CORPORATION
8.4.15.1. Company overview
8.4.15.2. Financial performance
8.4.15.3. Product benchmarking
8.4.15.4. Strategic initiatives
8.4.16. ZIMMER & PEACOCK AS
8.4.16.1. Company overview
8.4.16.2. Financial performance
8.4.16.3. Product benchmarking
8.4.16.4. Strategic initiatives
8.4.17. SIEMENS HEALTHCARE
8.4.17.1. Company overview
8.4.17.2. Financial performance
8.4.17.3. Product benchmarking
8.4.17.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America biosensors market, by country, 2018 - 2030 USD Million and Volume Unit
Table 4 North America biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 5 North America biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 6 North America biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 7 U.S. biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 8 U.S. biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 9 U.S. biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 10 Canada biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 11 Canada biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 12 Canada biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 13 Europe biosensors market, by country, 2018 - 2030 USD Million and Volume Unit
Table 14 Europe biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 15 Europe biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 16 Europe biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 17 UK biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 18 UK biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 19 UK biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 20 Germany biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 21 Germany biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 22 Germany biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 23 France biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 24 France biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 25 France biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 26 Italy biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 27 Italy biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 28 Italy biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 29 Spain biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 30 Spain biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 31 Spain biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 32 Belgium biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 33 Belgium biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 34 Belgium biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 35 Switzerland biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 36 Switzerland biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 37 Switzerland biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 38 Netherlands biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 39 Netherlands biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 40 Netherlands biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 41 Sweden biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 42 Sweden biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 43 Sweden biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 44 Norway biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 45 Norway biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 46 Norway biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 47 Denmark biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 48 Denmark biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 49 Denmark biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 50 Asia Pacific biosensors market, by country, 2018 - 2030 USD Million and Volume Unit
Table 51 Asia Pacific biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 52 Asia Pacific biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 53 Asia Pacific biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 54 China biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 55 China biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 56 China biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 57 Japan biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 58 Japan biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 59 Japan biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 60 India biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 61 India biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 62 India biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 63 Australia biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 64 Australia biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 65 Australia biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 66 South Korea biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 67 South Korea biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 68 South Korea biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 69 Indonesia biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 70 Indonesia biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 71 Indonesia biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 72 Thailand biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 73 Thailand biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 74 Thailand biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 75 Latin America biosensors market, by country, 2018 - 2030 USD Million and Volume Unit
Table 76 Latin America biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 77 Latin America biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 78 Latin America biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 79 Brazil biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 80 Brazil biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 81 Brazil biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 82 Mexico biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 83 Mexico biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 84 Mexico biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 85 Argentina biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 86 Argentina biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 87 Argentina biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 88 Colombia biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 89 Colombia biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 90 Colombia biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 91 Middle East & Africa biosensors market, by country, 2018 - 2030 USD Million and Volume Unit
Table 92 Middle East & Africa biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 93 Middle East & Africa biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 94 Middle East & Africa biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 95 South Africa biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 96 South Africa biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 97 South Africa biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 98 Saudi Arabia biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 99 Saudi Arabia biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 100 Saudi Arabia biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 101 UAE biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 102 UAE biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 103 UAE biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 104 Turkey biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 105 Turkey biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 106 Turkey biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
Table 107 Kuwait biosensors market, by technology, 2018 - 2030 USD Million and Volume Unit
Table 108 Kuwait biosensors market, by application, 2018 - 2030 USD Million and Volume Unit
Table 109 Kuwait biosensors market, by end user, 2018 - 2030 USD Million and Volume Unit
List of Figures
Fig. 1 Biosensors market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2023)
Fig. 10 Segment outlook
Fig. 11 Strategy framework
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Consumer behavior analysis
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Biosensors market: Technology movement analysis
Fig. 19 Segment dashboard
Fig. 20 Biosensors market technology outlook: Key takeaways
Fig. 21 Thermal market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 22 Electrochemical market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 23 Piezoelectric market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 24 Optical market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 25 Biosensors market: Application movement analysis
Fig. 26 Segment dashboard
Fig. 27 Biosensors market application outlook: Key takeaways
Fig. 28 Medical market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 29 Cholesterol market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 30 Blood glucose market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 31 Blood gas analyzer market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 32 Pregnancy testing market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 33 Drug discovery market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 34 Infectious disease market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 35 Food toxicity market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 36 Bioreactor market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 37 Agriculture market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 38 Environment market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 39 Others market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 40 Biosensors market: End User movement analysis
Fig. 41 Segment dashboard
Fig. 42 Biosensors market end user outlook: Key takeaways
Fig. 43 Home healthcare diagnostics market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 44 PoC testing market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 45 Food industry market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 46 Research laboratories market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 47 Security and bio-defense market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 48 Regional outlook, 2022 & 2030
Fig. 49 Regional market dashboard
Fig. 50 Regional market place: Key takeaways
Fig. 51 North America biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 52 U.S. biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 53 Canada biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 54 Europe biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 55 UK biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 56 Germany biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 57 France biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 58 Italy biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 59 Spain biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 60 Belgium biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 61 Switzerland biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 62 Netherlands biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 63 Sweden biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 64 Norway biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 65 Denmark biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 66 Asia Pacific biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 67 Japan biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 68 China biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 69 South Korea biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 70 Indonesia biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 71 Thailand biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 72 Australia biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 73 India biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 74 Latin America biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 75 Brazil biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 76 Mexico biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 77 Argentina biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 78 Colombia biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 79 MEA biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 80 South Africa biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 81 Saudi Arabia biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 82 UAE biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 83 Turkey biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 84 Kuwait biosensors market, 2018 - 2030 (USD Million and Volume Unit)
Fig. 85 Company market share analysis, 2021
Fig. 86 Market differentiators
Fig. 87 Regional network mapMarket Segmentation
- Biosensors Technology Outlook (Volume, Unit; Revenue, USD Million, 2018 - 2030)
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Biosensors Application Outlook (Volume, Unit; Revenue, USD Million, 2018 - 2030)
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Biosensors End-user Outlook (Volume, Unit; Revenue, USD Million, 2018 - 2030)
- Home Healthcare Diagnostics
- PoC Testing
- Food Industry
- Research Laboratories
- Security & Bio-Defense
- Biosensors Regional Outlook (Volume, Unit; Revenue, USD Million, 2018 - 2030)
- North America
- North America Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- North America Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- North America Biosensors Market, By End-user
- Home Healthcare Diagnostics
- POC Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- U.S.
- U.S. Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- U.S. Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- U.S. Biosensors Market, By End-user
- Home Healthcare Diagnostics
- POC Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- U.S. Biosensors Market, By Technology
- Canada
- Canada Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Canada Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Canada Biosensors Market, By End-user
- Home Healthcare Diagnostics
- POC Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- Canada Biosensors Market, By Technology
- North America Biosensors Market, By Technology
- Europe
- Europe Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Europe Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Europe Biosensors Market, By End-user
- Home Healthcare Diagnostics
- POC Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- UK
- UK Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- UK Biosensors Market, By Technology
- UK Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- UK Biosensors Market, By End-user
- Home Healthcare Diagnostics
- POC Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- Germany
- Germany Biosensors Market, By Technology
-
- Thermal
- Electrochemical
- Piezoelectric
- Optical
-
- Germany Biosensors Market, By Application
-
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
-
- Germany Biosensors Market, By End-user
- Home Healthcare Diagnostics
- POC Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- Germany Biosensors Market, By Technology
- France
- France Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- France Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- France Biosensors Market, By End-user
- Home Healthcare Diagnostics
- POC Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- France Biosensors Market, By Technology
- Italy
- Italy Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Italy Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Italy Biosensors Market, By End-user
- Home Healthcare Diagnostics
- POC Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- Italy Biosensors Market, By Technology
- Spain
- Spain Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Spain Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Spain Biosensors Market, By End-user
- Home Healthcare Diagnostics
- POC Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- Spain Biosensors Market, By Technology
- Denmark
- Denmark Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Denmark Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Denmark Biosensors Market, By End-user
- Home Healthcare Diagnostics
- POC Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- Denmark Biosensors Market, By Technology
- Belgium
- Belgium Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Belgium Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Belgium Biosensors Market, By End-user
- Home Healthcare Diagnostics
- POC Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- Belgium Biosensors Market, By Technology
- Switzerland
- Switzerland Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Switzerland Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Switzerland Biosensors Market, By End-user
- Home Healthcare Diagnostics
- POC Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- Switzerland Biosensors Market, By Technology
- Netherland
- Netherland Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Netherland Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Netherland Biosensors Market, By End-user
- Home Healthcare Diagnostics
- POC Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- Netherland Biosensors Market, By Technology
- Norway
- Norway Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Norway Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Norway Biosensors Market, By End-user
- Home Healthcare Diagnostics
- POC Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- Norway Biosensors Market, By Technology
- Sweden
- Sweden Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Sweden Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Sweden Biosensors Market, By End-user
- Home Healthcare Diagnostics
- POC Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- Sweden Biosensors Market, By Technology
- Europe Biosensors Market, By Technology
- Asia Pacific
- Asia Pacific Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Asia Pacific Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Asia Pacific Biosensors Market, By End-user
- Home Healthcare Diagnostics
- POC Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- China
- China Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- China Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- China Biosensors Market, By End-user
- Home Healthcare Diagnostics
- Poc Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- China Biosensors Market, By Technology
- Japan
- Japan Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Japan Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Japan Biosensors Market, By End-user
- Home Healthcare Diagnostics
- Poc Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- Japan Biosensors Market, By Technology
- India
- India Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- India Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- India Biosensors Market, By End-user
- Home Healthcare Diagnostics
- Poc Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- India Biosensors Market, By Technology
- Australia
- Australia Biosensors Market, By Technology
-
- Thermal
- Electrochemical
- Piezoelectric
- Optical
-
- Australia Biosensors Market, By Application
-
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
-
- Australia Biosensors Market, By End-user
- Home Healthcare Diagnostics
- Poc Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- Australia Biosensors Market, By Technology
- South Korea
- South Korea Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- South Korea Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- South Korea Biosensors Market, By End-user
- Home Healthcare Diagnostics
- Poc Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- South Korea Biosensors Market, By Technology
- Indonesia
- Indonesia Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Indonesia Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Indonesia Biosensors Market, By End-user
- Home Healthcare Diagnostics
- Poc Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- Indonesia Biosensors Market, By Technology
- Thailand
- Thailand Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Thailand Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Thailand Biosensors Market, By End-user
- Home Healthcare Diagnostics
- Poc Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- Thailand Biosensors Market, By Technology
- Asia Pacific Biosensors Market, By Technology
- Latin America
- Latin America Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Latin America Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Latin America Biosensors Market, By End-user
- Home healthcare diagnostics
- PoC testing
- Food industry
- Research laboratories
- Security and bio-defense
- Brazil
- Brazil Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Brazil Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Brazil Biosensors Market, By End-user
- Home healthcare diagnostics
- PoC testing
- Food industry
- Research laboratories
- Security and bio-defense
- Brazil Biosensors Market, By Technology
- Mexico
- Mexico Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Mexico Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Mexico Biosensors Market, By End-user
- Home healthcare diagnostics
- PoC testing
- Food industry
- Research laboratories
- Security and bio-defense
- Mexico Biosensors Market, By Technology
- Argentina
- Argentina Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Argentina Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Argentina Biosensors Market, By End-user
- Home healthcare diagnostics
- PoC testing
- Food industry
- Research laboratories
- Security and bio-defense
- Argentina Biosensors Market, By Technology
- Colombia
- Colombia Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Colombia Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Colombia Biosensors Market, By End-user
- Home Healthcare Diagnostics
- Poc Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- Colombia Biosensors Market, By Technology
- Latin America Biosensors Market, By Technology
- Middle East and Africa
- Middle East and Africa Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Middle East and Africa Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Middle East and Africa Biosensors Market, By End-user
- Home Healthcare Diagnostics
- Poc Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- South Africa
- South Africa Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- South Africa Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- South Africa Biosensors Market, By End-user
- Home Healthcare Diagnostics
- Poc Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- South Africa Biosensors Market, By Technology
- UAE
- UAE Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- UAE Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- UAE Biosensors Market, By End-user
- Home Healthcare Diagnostics
- Poc Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- UAE Biosensors Market, By Technology
- Saudi Arabia
- Saudi Arabia Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Saudi Arabia Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Saudi Arabia Biosensors Market, By End-user
- Home Healthcare Diagnostics
- Poc Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- Saudi Arabia Biosensors Market, By Technology
- Turkey
- Turkey Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Turkey Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Turkey Biosensors Market, By End-user
- Home Healthcare Diagnostics
- Poc Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- Turkey Biosensors Market, By Technology
- Kuwait
- Kuwait Biosensors Market, By Technology
- Thermal
- Electrochemical
- Piezoelectric
- Optical
- Kuwait Biosensors Market, By Application
- Medical
- Cholesterol
- Blood glucose
- Blood gas analyzer
- Pregnancy testing
- Drug discovery
- Infectious disease
- Food Toxicity
- Bioreactor
- Agriculture
- Environment
- Others
- Medical
- Kuwait Biosensors Market, By End-user
- Home Healthcare Diagnostics
- Poc Testing
- Food Industry
- Research Laboratories
- Security and Bio-Defense
- Kuwait Biosensors Market, By Technology
- Middle East and Africa Biosensors Market, By Technology
- North America
Biosensors Market Dynamics
Drivers: Various Applications Of Biosensors In Medical Fields
Early and precise disease diagnosis is essential for the survival of patients and the successful prognosis of diseases. In recent years, the demand for simple, disposable, user-friendly, and cost-efficient devices with fast response time has increased extensively. Biosensors fulfill all these criteria. Biosensors for the measurement of glucose, urea, creatinine, and lactate, using both electrochemical and optical modes of transduction, are being used and commercially developed in laboratories, self-testing, point-of-care testing, and in glucose monitoring. Biosensors have applications in various areas of the healthcare industry such as cardiovascular, cancer, and diabetes. The rising incidence of diabetes and cardiovascular diseases globally has led to an increase in the use of biosensors for early detection of these diseases. Biosensors are ideal for new applications in hospitals, by patients at home, and by caregivers in non-hospital settings, thus boosting the use of biosensors.
Drivers: Rising Prevalence Of Diabetes
The rising prevalence of diabetes across the globe is anticipated to boost the market growth. Factors such as antimicrobial resistance, adoption of unhealthy & sedentary lifestyles, alcohol consumption, and smoking are some of the major factors contributing to the rise in the prevalence of diabetes. According to the National Diabetes Statistic Report 2017, published by the Centers for Disease Control and Prevention (CDC), more than 100.0 million people in the U.S. were living with diabetes or prediabetes conditions. In addition, WHO reported that in 2016 approximately 1.6 million deaths globally were directly caused due to diabetes. As per the WorldAtlas, in 2018, the top ten countries with the highest prevalence rate of diabetes are Saudi Arabia (17.7%), Soloman Islands (18.7%), Guam (21.5%), Mauritius (22%), French Polynesia (22.6%), Kiribati (22.7%), New Caledonia (23.4%), Nauru (24.1%), Tuvalu (27.3%), and Marshall Islands (30.5%).
Restraints: High Cost Of Research & Development
There is a need to develop compatible single-task tools in combination with the available software. A large amount of data with a lack of standardization has impeded the growth of the biosensors market. There is a need for a user-friendly database to reduce the effort and time associated with the analysis of the large data available to institutions and governments globally. Enhancement of integration methods is also required to overcome statistical challenges arising due to integrated analysis of high-throughput biomedical research and genomic data. Constant addition of new genomes in public sequences databases is also leading to errors, hence making standardization crucial for optimum results of simulation and modeling.
What Does This Report Include?
This section will provide insights into the contents included in this biosensors market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Biosensors market qualitative analysis
-
Industry overview
-
Industry trends
-
Market drivers and restraints
-
Market size
-
Growth prospects
-
Porter’s analysis
-
PESTEL analysis
-
Key market opportunities prioritized
-
Competitive landscape
-
Company overview
-
Financial performance
-
Product benchmarking
-
Latest strategic developments
-
Biosensors market quantitative analysis
-
Market size, estimates, and forecast from 2018 to 2030
-
Market estimates and forecast for product segments up to 2030
-
Regional market size and forecast for product segments up to 2030
-
Market estimates and forecast for application segments up to 2030
-
Regional market size and forecast for application segments up to 2030
-
Company financial performance
Research Methodology
A three-pronged approach was followed for deducing the biosensors market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:
Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for biosensors market to gather the most reliable and current information possible.
- We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
- We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
- We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
- We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
- We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.
Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of biosensors market data depending on the type of information we’re trying to uncover in our research.
-
Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.
-
Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.
-
Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.
-
Qualitative Functional Deployment (QFD) Modelling for market share assessment.
Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.
-
Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.
-
Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.
-
This step also entails the finalization of the report scope and data representation pattern.
-
Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.
Biosensors Market Categorization:
The biosensors market was categorized into four segments, namely technology (Thermal, Electrochemical, Piezoelectric, Optical), application (Medical, Cholesterol, Blood Glucose, Blood Gas Analyzer, Pregnancy Testing, Drug Discovery, Infectious Disease, Food Toxicity, Bioreactor, Agriculture, Environment), end-user (Home Healthcare Diagnostics, POC Testing, Food Industry, Research Laboratories, Security and Bio-Defense), and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).
Segment Market Methodology:
The biosensors market was segmented into technology, application, end-user, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:
Market research approaches: Bottom-up
-
Demand estimation of each product across countries/regions summed up to from the total market.
-
Variable analysis for demand forecast.
-
Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.
-
Primary interviews for data revalidation and insight collection.
Market research approaches: Top-down
-
Used extensively for new product forecasting or analyzing penetration levels.
-
Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.
-
Primary interviews and vendor-based primary research for variable impact analysis.
Market research approaches: Combined
- This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.
Regional Market Methodology:
The biosensors market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-five countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Belgium; Switzerland; The Netherlands; Russia; Japan; China; India; Australia; South Korea; Indonesia; Brazil; Mexico; Colombia; Argentina; South Africa; Saudi Arabia; UAE; Turkey.
All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.
Biosensors market companies & financials:
The biosensors market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:
-
ABBOTT - Abbott is a global healthcare company focused on the development, manufacture, and commercialization of healthcare products across the globe. The company operates through four segments: pharmaceutical products, diagnostic products, nutritional products, and medical devices. Abbott’s product segment offers generic medicines for pain, fever, pancreatic disorders, hypertension, cardiovascular & metabolic products, and vaccines. The medical devices products segment of the company includes vascular & structural heart devices, electrophysiology & rhythm management, as well as heart failure devices for the treatment of cardiovascular diseases. In addition, this segment offers neuromodulation devices for the management of movement disorders and chronic pain. The company also offers blood glucose monitoring systems. It has a global presence with operations in more than 160 countries. St. Jude Medical operates as a subsidiary of Abbott.
-
MEDTRONIC - Medtronic is a global health solutions company involved in the development, manufacture, distribution, and commercialization of device-based medical therapies & services. It operates through four segments: minimally invasive therapies, cardiac & vascular groups, restorative therapies, and diabetes groups. Their minimally invasive therapies segment consists of mesh fixation devices & hardware instruments; surgical products, including vessel sealing instruments, wound closure, and stapling devices; electro-surgery products; and mesh implants. In addition, it offers products in the fields of minimally invasive gastrointestinal diagnostics, inhalation therapy, renal care, and interventional lung solutions. The company has a global presence and operates from more than 370 locations in approximately 160 countries around the world. Its products are used mainly in surgical centers, hospitals, home care, and long-term care facilities. Medtronic markets its products through direct representatives in the U.S. and independent distributors & direct marketing methods in markets overseas.
-
BIOSENSOR INTERNATIONAL GROUP, LTD. - Biosensors International Group, Ltd. is a medical devices company that manufactures & commercializes devices for critical care and interventional cardiology procedures. It operates through four segments: interventional cardiology, cardiac diagnostic, licensing revenue, and critical care. It is the first company to develop and launch a biodegradable polymer stent, which reduces systemic exposure. It operates as a subsidiary of Blue Sail Medical Co. Ltd. The company does not manufacture or distribute interventional cardiology products in the U.S., as they are not approved by the U.S. FDA.
-
ASCENSIA DIABETES CARE HOLDINGS AG (PHC HOLDINGS) - Ascensia Diabetes Care Holdings AG is a part of Panasonic Healthcare Holdings, engaged in developing, manufacturing, and commercializing medical devices & solutions for diabetes management. It operates as a stand-alone company, established after the purchase of Bayer AG’s Diabetes Care by PHC Holdings in 2016. Its leading product includes CONTOUR brand blood glucose monitoring systems that are user-friendly and technologically advanced. The company has a strong pipeline and invests in R&D for new product development to improve patient care. It has a global presence and markets its products in more than 125 countries.
-
CRANFIELD BIOTECHNOLOGY CENTRE - Cranfield Biotechnology Centre is a clinical research unit that works under the Cranfield University. It is involved in R&D for disease prevention and detection. The research center is engaged in biomedical engineering for the development of point-of-care and hand-held diagnostic technologies using biosensors. These include lateral flow devices, assay platforms, and drug discovery technologies. The center provides clinical research capabilities for the development of biomedical diagnostics, nanomedicine, bioinformatics, biosensors, environmental & food monitoring, phenotypic assay technologies, and sensors for extreme environments. Major research expertise at Cranfield is in biosensors for defense & security, aerospace, transport systems, environment & agrifood, energy, and water.
-
PINNACLE TECHNOLOGIES, INC. - Pinnacle Technology Inc., is a preclinical research tools manufacturing company. The company is involved in research & designing of data acquisition and analytical solutions for the central nervous system. It develops sophisticated new tools for simplifying clinical research. The company offers biosensors, EEG/EMG, optogenetics, laboratory equipment, and video-tracking tools to analyze research in freely moving rodents. Pinnacle offers interventions and drugs for brain & sleep disorders, such as Parkinson’s disease, Huntington’s disease, and Schizophrenia.
-
DUPONT MATERIALS (DUPONT) - DuPont is a scientific materials and engineering technology company. It develops science-based products and is a services-oriented firm. The company offers its products and solutions through five reportable business segments: nutrition & biosciences, safety & construction, transportation & industrial, electronics & imaging, and non-core. It provides a range of products and services for communications, agriculture & food, building & construction, and transportation. It also produces a range of screen-printable inks that are utilized in metallurgy and organic systems as biosensors. These materials are also used in medical monitoring, drug delivery, food, diagnostics, and environmental sensors. The company has an international presence and operates in more than 90 countries.
-
ERCON, INC. - Ercon, Inc. is a privately held company involved in the manufacture and commercialization of electrochemical sensor coating electronics and medical diagnostics. The company designs polymer thick-film inks for printing diagnostic biosensors and electrodes. These inks are utilized in blood-glucose sensor test strips, body electrodes, touch screens, membrane switches, and RFID by using silver, silver/silver chloride, graphite, carbon, gold, platinum, and insulator materials. The company’s products are utilized worldwide for their high-quality products and services. Most of the glucose test strip manufacturing companies throughout the world use Ercon's inks to produce sensors available on the point-of-care market.
-
ANALOG DEVICES, INC. - Analog Devices, Inc. is a company segmented into four business units: communications, automotive, industrial, and healthcare business group. It specializes in digital, analog, & mixed signal processing and is involved in manufacturing semiconductors. The product portfolio of the company includes amplifiers, audio-video products, digital-to-analog converters, linear products, microwaves, and optical & other sensors. The company offers these products to more than 100,000 clients across a broad range of industries, including IT, automotive, Health imaging, communication, electronics, and others. Analog Devices has a global presence and operates in North & South America, Europe, Japan, and China.
-
SENSIRION AG SWITZERLAND - Sensirion AG Switzerland is one of the leading manufacturers of digital microsensors and systems for measurement & control of humidity, gas, & liquid flows. It is a spin-off of the Swiss Federal Institute of Technology, Zurich. Sensirion’s product range includes liquid and gas flow sensors, environmental sensors, and differential pressure sensors. It has a distribution network with sales offices in various countries, such as Korea, Japan, Taiwan, China, Europe, and the U.S. The company’s sensors are utilized in analytical instruments, consumer goods, HVAC products, and medical, industrial, and automotive sectors.
Value chain-based sizing & forecasting
Supply Side Estimates
-
Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.
-
Segment revenue determination via variable analysis and penetration modeling.
-
Competitive benchmarking to identify market leaders and their collective revenue shares.
-
Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.
Demand side estimates
-
Identifying parent markets and ancillary markets
-
Segment penetration analysis to obtain pertinent
-
revenue/volume
-
Heuristic forecasting with the help of subject matter experts
-
Forecasting via variable analysis
Biosensors Market Report Objectives:
-
Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.
-
Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.
-
Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2022, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.
Biosensors Market Report Assumptions:
-
The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.
-
The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.
-
We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.
-
All market estimates and forecasts have been validated through primary interviews with the key industry participants.
-
Inflation has not been accounted for to estimate and forecast the market.
-
Numbers may not add up due to rounding off.
-
Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).
-
Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).
-
Latin America includes Central American countries and the South American continent
-
Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.
Primary Research
GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.
We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:
-
Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.
-
Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.
The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.
![pdf icn]()
GET A FREE SAMPLE
![arrow icn]()
This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.
![gvr icn]()
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
![Certified Icon]()
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
